81N-0033 Oral Health Care Drug Products for OTC Human Use
LET 51 Consumer Healthcare Products Association Vol#: 70
97S-0163 Dietary Supplements, Courtesy Letters (Letters of Objection)
LET 580 HFS-810 to Enzymatic Therapy, Inc. Vol#: 17
LET 581 HFS-810 to Integrative Therapeutics Inc Vol#: 17
LET 582 HFS-810 to American Biotech Labs Vol#: 17
LET 583 HFS-810 to Natrol Inc Vol#: 17
LET 584 HFS-810 to Life Plus International Vol#: 17
LET 585 HFS-810 to Flora Inc Vol#: 17
LET 586 HFS-810 to Shanti Herbs Vol#: 17
LET 587 HFS-810 to Inverness Medical Inc Vol#: 17
LET 588 HFS-810 to Pharmavite Corporation Vol#: 17
LET 589 HFS-810 to Natural Organics Inc Vol#: 17
LET 590 HFS-810 to Gaia Herbs Vol#: 17
LET 591 HFS-810 to Shanti Herbs Vol#: 17
LET 592 HFS-810 to Market America Inc Vol#: 17
LET 593 HFS-810 to Solgar Vitamin & Herb Vol#: 17
LET 594 HFS-810 to Efficient Laboratories, Inc. Vol#: 17
LET 595 HFS-810 to Natural Factors Nutritonal Pr Vol#: 17
LET 596 HFS-810 to Neways Inc Vol#: 17
LET 597 HFS-810 to StarCor Pharmaceuticals Inc Vol#: 17
99N-4282 Biotechnology in the Year 2000 and Beyond; Public Meetings
EMC 3604 Shellie Willet Vol#: 511
EMC 3605 Edward Triska Vol#: 511
EMC 3606 Holly Owens Vol#: 511
99P-5332 Amend limit Hydrogenated & partially Hydrogenated Menhaden O
C 2 National Fisheries Institute Vol#: 1
NCR 1 Vol#: 1
00N-1571 Enrofloxacin for Poultry: Opportunity for hearing
RMO 1 Center for Veterinary Medicine Vol#: 126
WDL 1 Center for Veterinary Medicine Vol#: 126
01D-0577 Class II Special Controls Guidance Cutaneous Carbon Dioxide
C 1 Linde Medical Sensors AG Vol#: 1
01E-0363 Patent Term Extension Application, MIFEPREX No. 4,386,085
NEC 1 Vol#: 1
01N-0266 Medical Device Registration and Listing
NAL 1 Vol#: 1
SS 1 SUPPORTING STATEMENT Vol#: 1
01N-0267 Agency Information Collection: Medical Device Labeling Reg
NAL 1 Vol#: 2
SS 1 SUPPORTING STATEMENT Vol#: 2
01N-0277 Reports of Corrections and Removals:Agency Information Colle
NAL 1 Vol#: 1
SS 1 SUPPORTING STATEMENT Vol#: 1
01N-0399 Rapid Response Surveys;Agency Information Collection
NAL 1 Vol#: 1
SS 1 SUPPORTING STATEMENT Vol#: 1
01P-0471 Issue the NFR Placement of Anthrax Vaccine as Category II
LET 1 HFM-1 to Russell E Dingle Vol#: 1
02N-0010 Intraoral Devices for Snoring/Obstructive Sleep Apnea
NPR 1 Vol#: 1
02N-0109 Disemination information unapproved/new use for marketed dru
N 1 Vol#: 1
02N-0112 Regulations Under the Federal Import Milk Act
N 1 Vol#: 1
02P-0161 ANDA Suitability for Isotretinoin Capsules 30 mg
CP 1 Lachman Consultant Services, Inc. Vol#: 1
02P-0163 Expedite Over-the-Counter Approval for Desloratidine
CP 1 WellPoint Health Networks Vol#: 1
02V-0162 Laser Light Show Projector
ACK 1 HFA-305 Vol#: 1
VAR 1 Metropolitan Opera Association Vol#: 1